- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Sustainable Track Record
Indian Pharmaceuticals & Biotech Sustainable Track Record
UPDATED May 14, 2024
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
20 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CONCORDBIO | ₹1,503.30 | -3.5% | n/a | ₹157.3b | ₹1,596.80 | PE51.6x | E23.8% | 0% | ||
539561 | ₹80.60 | -17.8% | -0.5% | ₹8.1b | n/a | PE15.4x | n/a | n/a | ||
540737 | ₹578.25 | -5.2% | 94.7% | ₹7.4b | n/a | PE33.8x | n/a | 0.09% | ||
500488 | ₹26,784.50 | 4.2% | 26.5% | ₹569.2b | ₹27,741.86 | PE47.4x | E10.0% | 1.2% | ||
506820 | ₹5,444.55 | 4.6% | 65.6% | ₹136.1b | n/a | PE97.7x | n/a | 0.3% | ||
506260 | ₹241.60 | 3.1% | 158.0% | ₹12.1b | n/a | PE22.3x | n/a | 0.8% | ||
AJANTPHARM | ₹2,438.25 | 1.7% | 92.5% | ₹304.5b | ₹2,440.10 | PE37.3x | E13.3% | 1.5% | ||
MANKIND | ₹2,248.75 | 1.4% | 65.5% | ₹900.8b | ₹2,186.42 | PE52.2x | E18.7% | n/a | ||
524632 | ₹111.48 | 10.3% | 346.4% | ₹4.9b | n/a | PE26.3x | n/a | 0.1% | ||
530477 | ₹203.75 | -3.6% | 157.3% | ₹6.4b | n/a | PE26.2x | n/a | 0.2% | ||
524558 | ₹6,166.10 | -16.2% | 108.7% | ₹79.1b | ₹8,300.00 | PE26.4x | E12.2% | 0.2% | ||
500420 | ₹2,630.15 | 0.5% | 62.0% | ₹890.2b | ₹2,728.79 | PE59.6x | E21.3% | 1.1% | ||
524742 | ₹1,329.00 | 2.8% | 84.9% | ₹100.9b | ₹1,579.33 | PE23.1x | E1.0% | 0.4% | ||
500660 | ₹1,999.15 | -1.9% | 54.9% | ₹338.7b | ₹2,141.25 | PE64x | E21.1% | 1.6% | ||
INDGN | ₹554.45 | n/a | n/a | ₹132.7b | n/a | PE45.6x | n/a | n/a | ||
RPGLIFE | ₹1,482.90 | 4.0% | 90.2% | ₹24.5b | n/a | PE28x | n/a | 1.1% | ||
INNOVACAP | ₹468.90 | 2.8% | n/a | ₹26.8b | n/a | PE32.4x | n/a | n/a | ||
JSLL | ₹1,121.40 | 4.9% | 505.0% | ₹27.9b | n/a | PE51.1x | n/a | 0.1% | ||
BETA | ₹1,314.80 | 2.0% | 73.0% | ₹12.6b | n/a | PE36.4x | n/a | n/a | ||
531569 | ₹185.10 | 6.0% | 234.1% | ₹2.2b | n/a | PE36.6x | n/a | n/a |
Page 1 of 1